298 related articles for article (PubMed ID: 8755541)
41. Estrogen inhibition of Mullerian inhibiting substance in the chick embryo.
Hutson JM; Ikawa H; Donahoe PK
J Pediatr Surg; 1982 Dec; 17(6):953-9. PubMed ID: 6897657
[TBL] [Abstract][Full Text] [Related]
42. Müllerian inhibiting substance inhibits testosterone synthesis in adult rats.
Sriraman V; Niu E; Matias JR; Donahoe PK; MacLaughlin DT; Hardy MP; Lee MM
J Androl; 2001; 22(5):750-8. PubMed ID: 11545286
[TBL] [Abstract][Full Text] [Related]
43. Origin of anti-Müllerian hormone in bovine freemartin fetuses.
Vigier B; Tran D; Legeai L; Bézard J; Josso N
J Reprod Fertil; 1984 Mar; 70(2):473-9. PubMed ID: 6546587
[TBL] [Abstract][Full Text] [Related]
44. Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases.
Seidah NG; Benjannet S; Pareek S; Savaria D; Hamelin J; Goulet B; Laliberte J; Lazure C; Chrétien M; Murphy RA
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):951-60. PubMed ID: 8615794
[TBL] [Abstract][Full Text] [Related]
45. Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression.
Zhan Y; Fujino A; MacLaughlin DT; Manganaro TF; Szotek PP; Arango NA; Teixeira J; Donahoe PK
Development; 2006 Jun; 133(12):2359-69. PubMed ID: 16687449
[TBL] [Abstract][Full Text] [Related]
46. Müllerian inhibiting substance is present in testes of dogs with persistent müllerian duct syndrome.
Meyers-Wallen VN; Donahoe PK; Ueno S; Manganaro TF; Patterson DF
Biol Reprod; 1989 Nov; 41(5):881-8. PubMed ID: 2576223
[TBL] [Abstract][Full Text] [Related]
47. Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.
Donahoe PK; Clarke T; Teixeira J; Maheswaran S; MacLaughlin DT
Mol Cell Endocrinol; 2003 Dec; 211(1-2):37-42. PubMed ID: 14656474
[TBL] [Abstract][Full Text] [Related]
48. Müllerian inhibiting substance in sex-reversed dogs.
Meyers-Wallen VN; Donahoe PK; Manganaro T; Patterson DF
Biol Reprod; 1987 Nov; 37(4):1015-22. PubMed ID: 3689844
[TBL] [Abstract][Full Text] [Related]
49. Prohormone-converting enzymes: regulation and evaluation of function using antisense RNA.
Bloomquist BT; Eipper BA; Mains RE
Mol Endocrinol; 1991 Dec; 5(12):2014-24. PubMed ID: 1791845
[TBL] [Abstract][Full Text] [Related]
50. Sexually dimorphic expression of a teleost homologue of Müllerian inhibiting substance during gonadal sex differentiation in Japanese flounder, Paralichthys olivaceus.
Yoshinaga N; Shiraishi E; Yamamoto T; Iguchi T; Abe S; Kitano T
Biochem Biophys Res Commun; 2004 Sep; 322(2):508-13. PubMed ID: 15325259
[TBL] [Abstract][Full Text] [Related]
51. Proteolytic cleavage of wild type and mutants of the F protein of human parainfluenza virus type 3 by two subtilisin-like endoproteases, furin and Kex2.
Ortmann D; Ohuchi M; Angliker H; Shaw E; Garten W; Klenk HD
J Virol; 1994 Apr; 68(4):2772-6. PubMed ID: 8139055
[TBL] [Abstract][Full Text] [Related]
52. Role of prohormone convertases in pro-neuropeptide Y processing: coexpression and in vitro kinetic investigations.
Brakch N; Rist B; Beck-Sickinger AG; Goenaga J; Wittek R; Bürger E; Brunner HR; Grouzmann E
Biochemistry; 1997 Dec; 36(51):16309-20. PubMed ID: 9405066
[TBL] [Abstract][Full Text] [Related]
53. Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily.
Wilson CA; di Clemente N; Ehrenfels C; Pepinsky RB; Josso N; Vigier B; Cate RL
Mol Endocrinol; 1993 Feb; 7(2):247-57. PubMed ID: 8469238
[TBL] [Abstract][Full Text] [Related]
54. Müllerian inhibiting substance: new perspectives and future directions.
Catlin EA; MacLaughlin DT; Donahoe PK
Microsc Res Tech; 1993 Jun; 25(2):121-33. PubMed ID: 8518480
[TBL] [Abstract][Full Text] [Related]
55. Comparative processing of bovine leukemia virus envelope glycoprotein gp72 by subtilisin/kexin-like mammalian convertases.
Zarkik S; Decroly E; Wattiez R; Seidah NG; Burny A; Ruysschaert JM
FEBS Lett; 1997 Apr; 406(1-2):205-10. PubMed ID: 9109419
[TBL] [Abstract][Full Text] [Related]
56. Production of müllerian-inhibiting substance (MIS) and sulfated glycoprotein-2 (SGP-2) associated with testicular differentiation in the XX mouse gonadal graft.
Taketo T
Ann N Y Acad Sci; 1991; 637():74-89. PubMed ID: 1785792
[No Abstract] [Full Text] [Related]
57. Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells.
Lee MM; Seah CC; Masiakos PT; Sottas CM; Preffer FI; Donahoe PK; Maclaughlin DT; Hardy MP
Endocrinology; 1999 Jun; 140(6):2819-27. PubMed ID: 10342873
[TBL] [Abstract][Full Text] [Related]
58. Sites of transcription of the Müllerian inhibiting substance gene in mouse testis.
Ao A; Erickson RP; Stalvey JR
Mol Reprod Dev; 1993 Jun; 35(2):159-64. PubMed ID: 8318221
[TBL] [Abstract][Full Text] [Related]
59. Müllerian inhibiting substance in reproduction and cancer.
Donahoe PK
Mol Reprod Dev; 1992 Jun; 32(2):168-72. PubMed ID: 1637555
[TBL] [Abstract][Full Text] [Related]
60. Structure and expression of mouse furin, a yeast Kex2-related protease. Lack of processing of coexpressed prorenin in GH4C1 cells.
Hatsuzawa K; Hosaka M; Nakagawa T; Nagase M; Shoda A; Murakami K; Nakayama K
J Biol Chem; 1990 Dec; 265(36):22075-8. PubMed ID: 2266110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
